- Home
- PCH vs VCYT Comparison
PCH vs VCYT Comparison
Compare PCH & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCH | VCYT |
|---|---|---|
| Founded | 1903 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | PCH | VCYT |
|---|---|---|
| Price | $40.80 | $42.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $45.67 | $45.38 |
| AVG Volume (30 Days) | 508.7K | ★ 997.0K |
| Earning Date | 01-26-2026 | 11-04-2025 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | ★ 312.61 | N/A |
| EPS | ★ 0.82 | 0.38 |
| Revenue | ★ $1,115,571,000.00 | $495,141,000.00 |
| Revenue This Year | $3.38 | $16.02 |
| Revenue Next Year | $1.91 | $10.74 |
| P/E Ratio | ★ $49.63 | $110.98 |
| Revenue Growth | 5.40 | ★ 16.41 |
| 52 Week Low | $36.82 | $22.61 |
| 52 Week High | $48.12 | $50.71 |
Technical Indicators
Market Signals| Indicator | PCH | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 56.73 | 47.63 |
| Support Level | $39.02 | $45.68 |
| Resistance Level | $40.14 | $45.17 |
| Average True Range (ATR) | 0.94 | 2.10 |
| MACD | 0.24 | -0.68 |
| Stochastic Oscillator | 69.86 | 15.69 |
Price Performance
Historical ComparisonAbout PCH PotlatchDeltic Corporation
PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.